DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20210787

Frequency of osteopenia and osteoporosis in patients with multiple sclerosis

Marjan Asadollahi, Zahra Hamed, Kourosh Gharagozli, Abolfazl Atalu, Behzad Nemati

Abstract


Background: Multiple sclerosis (MS) is one of the most important diseases of the central nervous system and one of the main causes of disability in young and middle age groups. Recent studies show that the risk of osteoporosis and osteopenia in MS patients is higher than the normal population which could be related to many factors. The aim of this study was to determine the frequency of osteopenia and osteoporosis among MS patients.

Methods: This descriptive cross-sectional study was performed on 30 patients with MS. Bone density of patients was assessed by bone mineral density (BMD) method. Necessary demographic and clinical information were collected by a checklist and then analyzed by statistical methods in SPSS version 16.

Results: Of all patients, 36.7% had osteoporosis and osteopenia. According to the results, 86.6% of patients had a decrease in bone density in the pelvic region and 50% in the lumbar spine. 43.3% of patients had osteopenia in the pelvic region and 36.7% in the lumbar spine.

Conclusions: The results showed that BMD was high in MS patients. Due to the problems of walking and lack of balance in these patients and the high probability of falling and fractures among them, paying attention to the problem of osteoporosis by early and repeated performing of BMD.


Keywords


BMD, Interferon, Multiple Sclerosis, Osteopenia, Osteoporosis

Full Text:

PDF

References


Brouwers JEM, Lambers FM, Rietbergen B, Ito K, Huiskes R. Comparison of bone loss induced by ovariectomy and neurectomy in rats analyzed by in vivo micro-CT. J Orthop Res. 2009;27(11):1521-7.

Siva A, Kantarci O. An introduction to the clinical spectrum of inflammatory demyelinating disorders of the central nervous system. Front Mult Scler. 1999;2:1-9.

Marrie RA, Cutter G, Tyry T, Vollmer T. A cross-sectional study of bone health in multiple sclerosis. Neurology. AAN Enterprises. 2009;73(17):1394-8.

Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, et al. Fracture history and bone loss in patients with MS. Neurology. AAN Enterprises. 1998;51(4):1161-5.

Yuan FL, Li X, Lu WG, Xu RS, Zhao YQ, Li CW, et al. Regulatory T cells as a potent target for controlling bone loss. Biochem Biophys Res Commun. 2010;402(2):173-6.

Seeman E. Bone modeling and remodeling. Crit Rev Eukaryot Gene Expr. 2009;19(3):82-94.

Epstein S, Inzerillo AM, Caminis J, Zaidi M. Disorders associated with acute rapid and severe bone loss. J Bone Miner Res. 2003;18(12):2083-94.

Krupp LB, Serafin DJ, Christodoulou C. Multiple sclerosis-associated fatigue. Informa Healthcare London; 2010.

Hughes JM, Petit M. Biological underpinnings of frost’s mechanostat thresholds: the important role of osteocytes. J Musculoskelet Neuronal Interact. 2010;10(2):128-35.

Smeltzer SC, Zimmerman V, Capriotti T. Osteoporosis risk and low bone mineral density in women with physical disabilities. Arch Phys Med Rehabil. 2015;86(3):582-6.

Garland DE, Adkins RH, Stewart CA, Ashford R, Vigil D. Regional Osteoporosis in Women Who Have a Complete Spinal Cord Injury. J Bone Surg. 2001;83(8):1195-200.

Marrie RA, Cutter G, Tyry T, Vollmer T. A cross-sectional study of bone health in multiple sclerosis. Neurology. AAN Enterprises. 2009;73(17):1394-8.

Weinstock GB, Gallagher E, Baier M, Green L, Feichter J, Patrick K, et al. Risk of bone loss in men with multiple sclerosis. Mult Scler. 2004;10(2):170-5.

Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology. Br Soc Rheumatology. 2000;39(12):1383-9.

Lips P, Bouillon R, Schoor NM, Vanderschueren D, Verschueren S, Kuchuk N, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol. 2010;73(3):277-85.

Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, et al. Fracture history and bone loss in patients with MS. Neurology. AAN Enterprises. 1998;51(4):1161-5.

Alajbegovic A, Loga N, Tiro N, Alajbegovic S, Todorovic L. Depression in multiple sclerosis patients. Med Arch. 2011;65(2):115.

Oleson CV. Osteoporosis in Multiple Sclerosis. In: Osteoporosis Rehabilitation. Springer, Cham. 2017.

Poole KES, Compston JE. Osteoporosis and its management. British Med J. 2006;6:1251-6.

Kampman MT, Eriksen EF, Holmøy T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications? Acta Neurol Scand. 2011;124:44-9.

Agha M, Taheri P, Hossain A, Mosavi M, Reza M, Amini Y, et al. Prevalence of osteoporosis among above 60 years old subjects referred to Ayatollah Taleghani hospital in Tehran and its relationship with age and sex. SJIMU. 2013;20(5):94-102.

Sioka C, Kyritsis AP, Fotopoulos A. Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci. 2009;287(1-2):1-6.

Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmøy T. Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome. Neurology. 2011;77(2):151-7.

Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Özkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005;23(4):309-13.

Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44(9):1687.

Yuan FL, Li X, Lu WG, Xu RS, Zhao YQ, Li CW, et al. Regulatory T cells as a potent target for controlling bone loss. Biochem Biophys Res Commun. 2010;402(2):173-6.

Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, et al. Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol. Blackwell Science Ltd. 2005;12(7):550-6.

Abraham AK, Ramanathan M, Guttman B, Mager DE. Mechanisms of interferon-β effects on bone homeostasis. Biochem Pharmacol. 2009;77(12):1757-62.

Kampman MT, Eriksen EF, Holmøy T. Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications? Acta Neurol Scand. 2011;124:44-9.

Schwid SR, Goodman AD, Puzas JE, McDermott MP, Mattson DH. Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol. 1996;53(8):753-7.